Clinical Trial Update: Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) [Phase 3]

View source ↗

Summary

A Phase III trial comparing R744 with epoetin beta in predialysis patients has completed, evaluating comparative efficacy in anemia management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• R744
• epoetin beta (epoetin beta)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Predialysis Patients | Phase 3 | Status: COMPLETED